AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
62.72
+0.35 (0.56%)
At close: Mar 23, 2026, 4:00 PM EDT
63.66
+0.94 (1.50%)
After-hours: Mar 23, 2026, 6:57 PM EDT

AnaptysBio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
238.2123.0835.9771.31495.73
Short-Term Investments
73.44262.29354.94369.9352.37
Cash & Short-Term Investments
311.64385.37390.9441.24548.1
Cash Growth
-19.13%-1.42%-11.41%-19.50%39.23%
Other Receivables
33.8540.776.851.420.88
Total Trade Receivables
33.8540.776.851.420.88
Other Current Assets
4.765.749.084.554.9
Total Current Assets
350.25431.88406.84447.21553.88
Net Property, Plant & Equipment
13.8916.2318.2719.9921.84
Long-Term Investments
-35.4727.03142.9467.1
Other Long-Term Assets
0.260.260.260.260.26
Total Assets
364.4483.83452.39610.38643.07
Accounts Payable
3.8744.72.781.74
Accrued Expenses
32.6739.530.9721.6312.85
Current Portion of Leases
2.081.931.781.641.51
Total Current Liabilities
38.6345.4337.4426.0516.1
Long-Term Leases
12.0314.1116.0417.8119.45
Other Long-Term Liabilities
276.53353.43310.81304.41251.09
Total Long-Term Liabilities
288.56367.54326.84322.23270.54
Total Liabilities
327.19412.97364.29348.28286.64
Common Stock
0.030.030.030.030.03
Additional Paid-in Capital
809.77829.86702.97717.8678.58
Accumulated Other Comprehensive Income
-0.020.31-0.8-5.25-0.42
Retained Earnings
-772.56-759.33-614.1-450.48-321.75
Shareholders' Equity
37.2170.8788.1262.1356.43
Total Liabilities & Equity
364.4483.83452.39610.38643.07
Total Debt
14.1116.0417.8119.4520.96
Net Cash (Debt)
297.53369.34373.09421.79527.14
Net Cash Growth
-19.44%-1.01%-11.55%-19.98%34.03%
Net Cash Per Share
10.3513.0113.8614.9819.22
Book Value
37.2170.8788.1262.1356.43
Book Value Per Share
1.292.503.279.3112.99
Tangible Book Value
37.2170.8788.1262.1356.43
Tangible Book Value Per Share
1.292.503.279.3112.99
Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q